199 related articles for article (PubMed ID: 35243639)
1. Did prescribing laws disproportionately affect opioid dispensing to Black patients?
Townsend TN; Bohnert ASB; Lagisetty P; Haffajee RL
Health Serv Res; 2022 Jun; 57(3):482-496. PubMed ID: 35243639
[TBL] [Abstract][Full Text] [Related]
2. Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees.
Gunadi C; Shi Y
Drug Alcohol Rev; 2023 Nov; 42(7):1658-1666. PubMed ID: 37946605
[TBL] [Abstract][Full Text] [Related]
3. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
4. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.
Stein BD; Sheng F; Taylor EA; Dick AW; Sorbero M; Pacula RL
Drug Alcohol Depend; 2022 Feb; 231():109232. PubMed ID: 35007956
[TBL] [Abstract][Full Text] [Related]
5. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.
Liang D; Guo H; Shi Y
Subst Abus; 2021; 42(3):294-301. PubMed ID: 31697195
[TBL] [Abstract][Full Text] [Related]
6. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
7. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
[TBL] [Abstract][Full Text] [Related]
8. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
[TBL] [Abstract][Full Text] [Related]
9. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
10. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
11. Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities.
Gunadi C; Shi Y
BMC Public Health; 2023 Jul; 23(1):1326. PubMed ID: 37434122
[TBL] [Abstract][Full Text] [Related]
12. Systematic Identification and Categorization of Opioid Prescribing and Dispensing Policies in 16 States and Washington, DC.
Andraka-Christou B; McAvoy E; Ohama M; Smart R; Vaiana ME; Taylor E; Stein BD
Pain Med; 2023 Feb; 24(2):130-138. PubMed ID: 35984301
[TBL] [Abstract][Full Text] [Related]
13. State pain management clinic policies and county opioid prescribing: A fixed effects analysis.
Frizzell LC; Vuolo M; Kelly BC
Drug Alcohol Depend; 2020 Nov; 216():108239. PubMed ID: 32854001
[TBL] [Abstract][Full Text] [Related]
14. Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.
McGinty EE; Bicket MC; Seewald NJ; Stuart EA; Alexander GC; Barry CL; McCourt AD; Rutkow L
Ann Intern Med; 2022 May; 175(5):617-627. PubMed ID: 35286141
[TBL] [Abstract][Full Text] [Related]
15. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
16. Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: Evidence from Kentucky.
Nguyen T; Meille G; Buchmueller T
Drug Alcohol Depend; 2023 Feb; 243():109759. PubMed ID: 36621199
[TBL] [Abstract][Full Text] [Related]
17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
19. Racial Inequality in Prescription Opioid Receipt - Role of Individual Health Systems.
Morden NE; Chyn D; Wood A; Meara E
N Engl J Med; 2021 Jul; 385(4):342-351. PubMed ID: 34289277
[TBL] [Abstract][Full Text] [Related]
20. Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution.
Davis CS; Piper BJ; Gertner AK; Rotter JS
Pain Med; 2020 Mar; 21(3):532-537. PubMed ID: 31365095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
